3871
Naphthol AS-BI Phosphoric Acid Solution
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleform
solution
Quality Level
shelf life
Expiry date on the label.
IVD
for in vitro diagnostic use
concentration
12.5 mg/mL
application(s)
hematology
histology
shipped in
wet ice
storage temp.
2-8°C
SMILES string
COc1ccccc1NC(=O)c2cc3cc(Br)ccc3cc2OP(O)(O)=O
InChI
1S/C18H15BrNO6P/c1-25-16-5-3-2-4-15(16)20-18(21)14-9-12-8-13(19)7-6-11(12)10-17(14)26-27(22,23)24/h2-10H,1H3,(H,20,21)(H2,22,23,24)
InChI key
HUXIAXQSTATULQ-UHFFFAOYSA-N
Application
For use in the Sigma Acid Phosphatase (TRAP) Procedure, Kit 387A
Other Notes
Napthol AS-BI phosphoric acid, 12.5 mg/mL.
Clase de almacenamiento
12 - Non Combustible Liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Contenido relacionado
Veronika Kozlova et al.
PloS one, 15(3), e0229170-e0229170 (2020-03-27)
Surface protein CD20 serves as the critical target of immunotherapy in various B-cell malignancies for decades, however its biological function and regulation remain largely elusive. Better understanding of CD20 function may help to design improved rational therapies to prevent development
Yi-Ju Pan et al.
Inflammation research : official journal of the European Histamine Research Society ... [et al.], 67(10), 847-861 (2018-08-16)
To investigate the amelioration effects of quetiapine on rheumatoid arthritis with RAW 264.7 macrophage and collagen-induced arthritis (CIA) DBA/1J mouse model. RAW 264.7 macrophage and DBA/1J mice. Lipopolysaccharide and collagen. RAW 264.7 macrophages stimulated by lipopolysaccharide (LPS) followed by quetiapine
Daniel P Duarte et al.
Nature communications, 11(1), 2319-2319 (2020-05-10)
Bruton's tyrosine kinase (Btk) is critical for B-cell maturation and activation. Btk loss-of-function mutations cause human X-linked agammaglobulinemia (XLA). In contrast, Btk signaling sustains growth of several B-cell neoplasms which may be treated with tyrosine kinase inhibitors (TKIs). Here, we